semaglutide shortage news november 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list FDA Announces End to Semaglutide

DoE is looking to accelerate the Phase I-to-Phase II transition

Quite a few of the familiar faces you've probably seen on the screen

You might notice better energy or recovery, but the placebo effect is strong

Current as of 5/1/26 Do any of your plans cover Weight Loss Drugs (GLP-1) if deemed medically necessary

Zheng, Jiang [Food and Chemical Toxicology, 2023, vol

In a population without specific risk factors for thyroid cancer, the benefits of GLP-1 RAs will largely outweigh the harm. The European Medicines Agency in October 2023 announced that they did not find a causal link between GLP-1s and thyroid cancer after a months-long review